Joint Replacement Devices Market Size to Hit $31.09 Billion by 2030 – MarketsandMarkets™

Delray Beach, FL, Sept. 16, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global joint replacement devices market size will grow from USD 23.42 billion in 2024 to USD 31.09 billion by 2030, at a CAGR of 4.8% during the forecast period. Market growth is fueled by the increasing prevalence of orthopedic disorders, particularly among the elderly population, rising demand for minimally invasive orthopedic surgical procedures, increasing sports injuries, growing healthcare access in developing countries, and advancements in robotic-assisted orthopedic surgeries and joint replacement technologies.

Get PDF Brochure - Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178584762

Key Market Highlights

• Market size, 2024: USD 23.42 billion
• Market forecast, 2030: USD 31.09 billion
• Growth rate: CAGR of 4.8% (2024–2030)
• Largest product segment: Knee replacement devices
• Largest end-user segment: Hospitals & surgical centers
• Largest regional market: North America
• Fastest growth opportunity: Robotic-assisted orthopedic surgeries and 3D printing
• Key players: Stryker (US), Johnson & Johnson MedTech (US), Zimmer Biomet Holdings, Inc. (US), Smith+Nephew (UK), and B. Braun (Germany)

Why This Market Matters

The joint replacement devices market is expanding as the prevalence of orthopedic disorders continues to increase, particularly among the growing elderly population. Age-related conditions such as osteoarthritis, osteoporosis, and fractures are increasing the need for orthopedic implants that improve mobility and quality of life. The rising number of orthopedic procedures, growing awareness of the benefits of orthopedic surgery, increasing demand for minimally invasive procedures, and improved healthcare access are further supporting market growth.

Market Overview

The joint replacement devices market is witnessing sustained growth as hospitals and surgical centers adopt advanced orthopedic implants and technologies to address the rising burden of orthopedic conditions. The market includes knee, hip, elbow, shoulder, wrist, ankle, and other joint replacement devices, as well as bone graft substitutes. Increasing investments in healthcare infrastructure, expansion of hospitals and surgical centers, and growing adoption of computer-assisted and robotic-assisted surgical procedures are creating additional opportunities for market players. Emerging economies such as India and China also offer substantial growth opportunities due to expanding healthcare access and increasing healthcare investments.

Analyst Perspective

The joint replacement industry is moving toward more technologically advanced and minimally invasive treatment approaches. Robotic-assisted orthopedic surgeries and 3D printing are creating opportunities for customized and precise joint replacement procedures. Robotic platforms can support surgeons in accessing complex anatomical areas, while 3D printing enables the development of customized implants based on individual patient anatomy. Companies that integrate robotics, advanced implant technologies, digital solutions, and customized treatment approaches into their portfolios are expected to strengthen their competitive positions over the coming years.
Speak to Our Analyst - Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=178584762

Segment Analysis

By product, the knee replacement devices segment accounted for the largest share of the joint replacement devices market in 2023. The market is categorized into knee replacement devices, hip replacement devices, elbow replacement devices, shoulder replacement devices, wrist replacement devices, ankle replacement devices, other joint replacement devices, and bone graft substitutes. The leading position of knee replacement devices is supported by the increasing prevalence of knee osteoarthritis and rising knee injury rates. Ongoing innovations in knee replacement devices are also facilitating their adoption in hospitals and other healthcare facilities.

By end user, the hospitals & surgical centers segment held the largest share of the market. The market is categorized by end user into hospitals & surgical centers, ambulatory care centers & trauma units, and orthopedic clinics. The ambulatory care centers & trauma units segment is expected to experience the highest CAGR during the forecast period. Increasing healthcare spending, investments in healthcare delivery systems, growing demand for computer-assisted surgical treatments, and rising numbers of joint replacement surgeries are supporting market growth across end-user settings.

Regional Analysis

North America is expected to be the largest regional market for joint replacement devices by 2029. The region held a significant market share in 2023 due to the rising incidence of orthopedic diseases, increasing obesity rates, growing number of road accidents, and rising patient preference for minimally invasive procedures. Increasing awareness of newly introduced treatment procedures and technologies among physicians and patients is also supporting demand for joint replacement devices.

Europe represents the second-largest market for orthopedic implants, supported by the rising need to curtail healthcare costs and increasing prevalence of bone diseases. Emerging economies such as India and China offer several opportunities for market growth due to improving healthcare infrastructure and increasing access to orthopedic treatments.

Key Industry Trends

• Increasing prevalence of orthopedic disorders
• Rising demand for minimally invasive orthopedic surgical procedures
• Growing adoption of robotic-assisted orthopedic surgeries
• Increasing use of 3D printing for customized implants and surgical planning
• Rising number of orthopedic procedures and joint replacement surgeries
• Increasing shift toward outpatient care
• Growing healthcare investments in emerging economies
• Increasing adoption of computer-assisted surgical treatments
• Rising awareness of advanced orthopedic treatment technologies

Competitive Landscape

The competitive landscape of the joint replacement devices market is led by established global companies including Stryker (US), Johnson & Johnson MedTech (US), Zimmer Biomet Holdings, Inc. (US), Smith+Nephew (UK), B. Braun (Germany), Globus Medical, Inc. (US), Arthrex, Inc. (US), Enovis (US), Acumed LLC (US), Orthofix Medical Inc. (US), MicroPort Scientific Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US), and Meril Life Sciences Pvt. Ltd. (India).

The joint replacement devices market is consolidated, with Zimmer Biomet Holdings, Inc., Stryker Corporation, and Johnson & Johnson MedTech holding significant market shares in 2023. These companies have adopted strategies including acquisitions, partnerships, collaborations, agreements, and expansions to strengthen their positions in the global market.

Stryker is among the leading companies in the global joint replacement devices market and has a strong presence across Europe, North America, the Middle East, Africa, and Asia Pacific. The company provides joint replacement devices through its Orthopaedics & Spine division and focuses on portfolio expansion, innovation, and research and development to address unmet customer needs.

Zimmer Biomet is another leading company in the joint replacement devices market, offering products through its Knees, Hips, and S.E.T segments. The company has a strong international presence and maintains a broad product portfolio, brand value among end users, and R&D capabilities.

Johnson & Johnson MedTech is a major player involved in the manufacturing, R&D, and marketing of joint replacement devices globally. The company focuses on technologically advanced products designed to enhance clinical outcomes and has collaborated with CrossRoads Extremity Systems to advance orthopedic care.

Related Reports
Surgical Devices Market
Orthopedic Devices Market

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/